We are excited to officially announce that Duke has elevated Duke-Margolis to a University Health Policy Institute! With this new recognition, Duke-Margolis will continue to address timely health policy challenges; amplify Duke’s collective ability to support research and education that impacts health policy locally, nationally, and across the globe; and deepen Duke’s recruitment and retention of dynamic faculty and scholars who will lead, research, and explore the most pressing health care challenges of the future. Read the press release here: https://duke.is/z/aqgs
Duke-Margolis Institute for Health Policy
Public Policy
Washington, District of Columbia 6,725 followers
Improving health and the value of health care through practical, innovative, and evidence-based policy solutions.
About us
The mission of Duke University's Robert J. Margolis, MD, Institute for Health Policy is to improve health, health equity, and the value of health care through practical, innovative, and evidence-based policy solutions. Duke-Margolis catalyzes Duke University's leading capabilities including interdisciplinary academic research and capacity for education and engagement, to inform policy making and implementation for better health and health care.
- Website
-
https://healthpolicy.duke.edu/
External link for Duke-Margolis Institute for Health Policy
- Industry
- Public Policy
- Company size
- 51-200 employees
- Headquarters
- Washington, District of Columbia
- Type
- Educational
- Founded
- 2016
Locations
-
Primary
Get directions
1201 Pennsylvania Ave NW
5th Floor
Washington, District of Columbia 20004, US
-
Get directions
100 Fuqua Dr
Box 90120
Durham, North Carolina 27708, US
Employees at Duke-Margolis Institute for Health Policy
-
Amanda McBroom, Ph.D.
-
Gerrit Hamre
Research Director at Duke-Margolis Center for Health Policy
-
Tiffany Chan
Program Coordinator |Accomplished higher education professional | Effective collaborator | Team-oriented
-
David Ridley
Faculty Director, Health Sector Management, Fuqua School of Business
Updates
-
Duke-Margolis Institute for Health Policy reposted this
WEBINAR | Join Duke-Margolis Institute for Health Policy on 12/4 at 1pm ET for its webinar, "Scaling Primary Care for High-Need Older Adults: Building a Home-Based Medical Care Ecosystem." Explore the challenges and opportunities to improve support for the health & social needs of homebound #OlderAdults. Attendees will also hear about the current landscape of home-based primary care, including learning from recent research and ways to build on the Centers for Medicare & Medicaid Services' advance primary care efforts. Learn more:: https://ow.ly/2aR450Uc10J
-
Our work to make health care more accessible and affordable is advanced through the generosity of individuals and organizations who share our vision. With Giving Tuesday on December 3, we hope you will consider making a gift to support our work. Our Health Policy Action Fund is open to gifts of any amount and will provide start-up funds to support our Emerging Initiatives that will address some of the most pressing health care challenges. Specifically, the Health Policy Action Fund enables Duke-Margolis to respond to emerging issues by pooling philanthropic funding to support policy analysis, development, and educational opportunities. This funding ensures that health policy is informed by science, analysis, and representative stakeholder voices. Learn more here: https://duke.is/b/gnhd
-
-
We're thankful for this exciting news! Policy Research Associate Beth Boyer and Visiting Fellow Tanisha Carino have co-authored an article in Health Affairs Forefront to discuss generic drug repurposing:
In their new Forefront article, Beth Boyer and Tanisha Carino from the Duke-Margolis Institute for Health Policy discuss how generic drug repurposing is an underused but promising tool for finding new, affordable therapies. Creating a pull incentive, they argue, can spur developers to finally explore the untapped potential in these drugs. "Most drugs have more than one potential use, and in fact, that first Food and Drug Administration (FDA) approval is just the tip of the iceberg for a drug. Researching new uses for generic drugs—also called generic drug repurposing—can unlock the full potential of the drugs on our pharmacy shelves. For example, the decades-old anti-inflammatory drug dexamethasone was repurposed as a treatment for hospitalized COVID-19 patients. Thalidomide provides another example of unlocking new uses of an older drug—originally used as a sedative it was later repurposed as a treatment for leprosy and then also for multiple myeloma." Read the full article here: https://bit.ly/4g0ftug
-
The Primary Care Collaborative has released a new report, "Primary Care: The MVP of MSSP," to examine the performance of primary care accountable care organizations in the Medicare Shared Savings Program. Visting Fellow David Muhlestein co-authored and Assistant Research Director Frank W. McStay II reviewed the report, and both spoke during the release event. Read more here: https://duke.is/z/qbwz
-
Duke-Margolis Institute for Health Policy reposted this
Join us for an exciting info session about the Duke-Margolis Summer Experience Internship Program! At the info session, we will share information about the internship, application process and answer any questions you might have! Open to undergraduate and graduate/PhD students; this is an opportunity to learn about the Duke-Margolis Institute, application process and hear from former interns. 📅 December 4 from 4:00-4:45pm ⏰Register Here for the info session: https://duke.is/g/pktk
-
-
A draft agenda is available for this upcoming event! Join us on December 10 for a virtual workshop, hosted under a cooperative agreement with the FDA, to review data regarding risks associated with the use of medications in the antipsychotic class in older adults with behavioral and psychiatric symptoms associated with dementia. Learn more and register here: https://duke.is/2/4dtc
-
-
Join us for an exciting info session about the Duke-Margolis Summer Experience Internship Program! At the info session, we will share information about the internship, application process and answer any questions you might have! Open to undergraduate and graduate/PhD students; this is an opportunity to learn about the Duke-Margolis Institute, application process and hear from former interns. 📅 December 4 from 4:00-4:45pm ⏰Register Here for the info session: https://duke.is/g/pktk
-
-
Join us on Wednesday, December 4, for our next webinar! We will be exploring challenges and opportunities to improve support for the health and social care needs of homebound older adults. You can learn more about this upcoming event and register here: https://duke.is/p/3ttz
-
-
Duke-Margolis researchers have published a new study in JAMA Network Open! You can read more about their work to analyze the participation of Federally Qualified Health Centers in Medicare Shared Savings Program Accountable Care Organizations below:
New study in JAMA Network Open examining the performance of Medicare Shared Savings Program ACOs by participation of FQHCs, with Yucheng Hou, Frank W. McStay II, Jonathan Gonzalez-Smith, and Robert Saunders. Increasing number of FQHCs have joined Medicare ACOs in the past decade, including the period likely being affected by the COVID-19 pandemic and Pathways to Success. The descriptive part of our study showed that ACOs that always had FQHC participants during 2016-22 were larger, provided care to more socioeconomically disadvantaged beneficiaries (characterized by dual eligibility, disability, and race and ethnicity), but had lower levels of quality measures related to preventive and primary care, compared to those without FQHC participants, possibly due to differences in patient panels of FQHCs and non-FQHC practices. In our difference-in-difference analysis, we examined the first-time inclusion of FQHCs and compared ACOs with similar baseline characteristics. We found that including first FQHCs was associated with enhanced ACOs’ reach to disadvantaged beneficiaries and levels of servral quality measures related to preventive care, without increasing costs or utilization.
Federally Qualified Health Centers and Performance of Medicare ACOs
jamanetwork.com